Europe Bio-Implants Market to Register Steady Growth During Forecast Period
Rising incidence of
orthopedic disorders is expected to drive the growth of Europe bio-implants
market
According
to TechSci Research report, “Europe
Bio-Implants Market By Type (Cardiovascular Bioimplants, Dental
Bioimplants, Orthopedic Bioimplants, Spinal Bioimplants, and Ophthalmology
Bioimplants), By Material (Metallic Biomaterials, Ceramic Biomaterials,
Polymers Biomaterials, Alloys and Natural Biomaterials), By Origin (Autograft,
Allograft, Synthetic, and Others), By End-User (Hospitals, Clinics, Specialty
Centers and Others), By Country, Competition, Forecast & Opportunities,
2025”, Europe bio-implants market is expected to witness significant
CAGR during the forecast period. Growing R&D activities is one of the major factors accounting for
the growth of Europe bio-implants market. For instance, several pacemaker
manufacturers are focusing more towards developing MRI-conditional and leadless
pacemakers, which is expected to boost the market growth. Moreover, increase in incidences of chronic diseases such as
osteoarthritis, old age-related trauma, neuropathic disorders, congenital
disorders, among others, is expected to bode well for the growth of Europe
bio-implants market through the forecast period. In addition to this, there are
certain advantage of bio-implants through the conventional forms of implants such
as it is a fast method of treatment with negligible complications, which is
projected to positively influence the growth of Europe bio-implants market in
the years to come. Also, rising adoption of cosmetic surgeries, is further
making headway for the growth of Europe bio-implants market over the coming
years. However, there are some factors that might act as major impediments to
the growth of Europe bio-implants market through 2025 including high treatment
costs and reimbursement issues.
Browse XX
market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on " Europe Bio-Implants Market
"
https://www.techsciresearch.com/report/europe-bio-implants-market/4963.html
Europe
bio-implants market can be segmented based on type,
material, origin, end-user, company, and region. In terms of origin, the market
can be categorized into autograft, allograft, synthetic, and others. Among
these, the allografts segment is expected to register high growth in the next five
years which is attributable to benefits such as lower risk of harvest site morbidity,
reduced postoperative pain, as well as shorter surgical and recovery time. Based
on type, the market can be categorized into cardiovascular bioimplants, dental
bioimplants, orthopedic bioimplants, spinal bioimplants, and ophthalmology
bioimplants. Out of these, the cardiovascular bioimplants segment dominated the
market in terms of largest market share until 2019 and is expected to maintain
its dominance during the forecast period as well which is mainly attributed to
rising prevalence of cardiovascular diseases. Along with this, dental implants
are expected to grow at a high pace during the forecast period due to growing ageing
population with more tooth deformities. Moreover, increasing demand for dental
and cosmetic surgeries is further anticipated to contribute to the segmental
growth over the coming years.
Medtronic Plc., St. Jude Medical Inc., Stryker
Corporation, Boston Scientific Corporation, Gore (WL) & Associates
Incorporated, Abbott Laboratories, Braun (B.) Melsungen AG, Zimmer Biomet
Holdings Inc., Orthofix Holdings, Inc., Wright Medical Group N.V., Johnson
& Johnson Services, Inc., Integra Life Sciences, Smith & Nephew Plc, Exactech,
Inc., Cochlear Ltd are among others are the leading players operating in
Europe bio-implants market. The players are adopting several growth strategies
to enhance the market scenario of bio-implants. Other competitive strategies
include new technological developments; new product launches, extensive
research activities, mergers & acquisitions; agreements, partnerships, and
collaborations; and expansions to diverse their product portfolio in order to
strengthen their market position.
download
sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4963
customers can also
request for 10% free customization on this report.
“Europe bio-implants market is anticipated to register high growth during
the next 5 years on account of growing government funding and support. Furthermore,
rising incidence of orthopedic disorders in the region is further anticipated
to boost the market growth for bio-implants over the coming years. Also,
upsurge in number of CVD surgeries, on account of rising prevalence of the
condition in the region is expected to aid the market growth in the next five
years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research
based global management consulting firm.
“Europe Bio-Implants Market By Type (Cardiovascular
Bioimplants, Dental Bioimplants, Orthopedic Bioimplants, Spinal Bioimplants,
and Ophthalmology Bioimplants), By Material (Metallic Biomaterials, Ceramic
Biomaterials, Polymers Biomaterials, Alloys and Natural Biomaterials), By
Origin (Autograft, Allograft, Synthetic, and Others), By End-User (Hospitals,
Clinics, Specialty Centers and Others), By Country, Competition, Forecast &
Opportunities, 2025” has
evaluated the future growth potential of Europe bio-implants market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in Europe bio-implants market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]